These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16575264

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J, Goral A, Paluszkiewicz P, Przesmycki K, Kotarski J.
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
    Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D.
    Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S.
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
    Dell'Utri D, Passariello M.
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE, van Mook WN, Ramsay G.
    Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant activated factor VII in cardiac surgery--will we ever know for sure?
    Silver DA, D'Ambra MN.
    Crit Care Med; 2007 Jul 01; 35(7):1782-3. PubMed ID: 17581365
    [No Abstract] [Full Text] [Related]

  • 12. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Verrijckt A, Proulx F, Morneau S, Vobecky S.
    J Thorac Cardiovasc Surg; 2004 Jun 01; 127(6):1812-3. PubMed ID: 15173742
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].
    Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszyński Z.
    Ginekol Pol; 2002 Mar 01; 73(3):230-3. PubMed ID: 12092258
    [Abstract] [Full Text] [Related]

  • 14. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
    El Kinge AR, Mahfouz RA, Shamseddine AI, Taher AT.
    Blood Coagul Fibrinolysis; 2007 Sep 01; 18(6):577-9. PubMed ID: 17762536
    [Abstract] [Full Text] [Related]

  • 15. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C, Lucía JF.
    Am J Hematol; 2007 Mar 01; 82(3):246-7. PubMed ID: 16924645
    [No Abstract] [Full Text] [Related]

  • 16. How we manage requests for recombinant factor VIIa (NovoSeven).
    Mathew P, Simon TL, Hunt KE, Crookston KP.
    Transfusion; 2007 Jan 01; 47(1):8-14. PubMed ID: 17207224
    [No Abstract] [Full Text] [Related]

  • 17. Fatal thrombotic event after infusion of recombinant activated factor VII after cardiac surgery.
    Pichon N, Bellec F, Sekkal S, Marsaud JP, Laskar M, François B, Vignon P.
    J Thorac Cardiovasc Surg; 2008 Jul 01; 136(1):220-1. PubMed ID: 18603082
    [No Abstract] [Full Text] [Related]

  • 18. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery.
    Morante L, Guasch EV, Palacio F, Gilsanz F.
    Anesth Analg; 2006 Jun 01; 102(6):1902-3. PubMed ID: 16717350
    [No Abstract] [Full Text] [Related]

  • 19. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
    Makris M, Hampton KK, Preston EE.
    Am J Hematol; 2001 Jan 01; 66(1):67-8. PubMed ID: 11426500
    [No Abstract] [Full Text] [Related]

  • 20. Invited commentary.
    Shander A, Javidroozi M.
    Ann Thorac Surg; 2008 Mar 01; 85(3):844. PubMed ID: 18291153
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.